| Top Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Debt Relief > Reduce Debt and Avoid Bankruptcy |
|
Top Articles - Reduce Debt and Avoid Bankruptcy
No one wants to consider bankruptcy. Bankruptcy leaves a big black mark on your credit report for anywhere from seven to ten years According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product . Bankruptcy alone could prevent you from buying a home, obtaining other forms of credit, or even renting a home for several years ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in This should only be used as a last resort, when all other efforts fail, and you simply have no other choice. At one time, bankru lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. tcy was seen as a way for people to find a new start in life. It was a way, to eliminate debt and start anew. However, with the ne here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe w laws that have recently been established, it is not so easy to file for bankruptcy, it is not as helpful as it once was, and the d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro e are many new requirements. Therefore, only use bankruptcy as a last result. Instead, find other ways to reduce debt, and work yo ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc r own way out of your financial hole. Working your way out of the hole of debt you may have inadvertently created and reduce debt easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi in that manner does two things. First, it allows you to gain insight on your spending history, thus improving it to essentially l nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically arn your lesson. Second, it shows creditors that you are learning your lesson and on your way to financial health instead of stayi and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ g in the red. Creditors are more likely to extend you credit and give you a second chance, when you reduce your own debt and show ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ffort, than they are if you file bankruptcy. Creditors look at bankruptcy as an easy way out, that you are not willing to correct ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a your own problems. You see, when you reduce debt with bankruptcy, you are going to have a hard time getting any type of credit. Y dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod u will be required to prove your credit worthiness once again. In other words, you typically have to go two to three years without cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin any negatives on your credit report at all. This means that you will have to pay all of your payments on time, every time. How ca tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen n you do this if they will not extend you credit? Well, you will just have to take what you can get. Of course, this is if you fil t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel bankruptcy. You cannot be late or delinquent on any payments to any person, including your utility companies. So, tell me, which ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ounds better? Filing bankruptcy and having to start all over again, at square one? Or perhaps, showing that you are serious and re y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products duce your debt the old fashion way, by paying it? Personally, the latter is the best choice for me. You have the opportunity to p . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ove yourself, you have the opportunity to show that you mean business, creditors will have a greater respect for you in this way. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ake it from me, a debt marked “paid in full”, even if it is late, looks a whole lot better on your credit report than “Bankruptcy” tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:When Leaders Succeed, Unfortunately
|